aTyr Pharma Announces FGFR4 as Receptor Target for AARS tRNA Synthetase Fragment
June 14, 2022 08:00 ET
|
aTyr Pharma, Inc.
Poster to be presented at the Keystone Symposia on Tissue Fibrosis and Repair. Second tRNA synthetase receptor identified from company’s platform. Findings suggest AARS fragment may have...